Sie suchten nach: VX-702

Lieferant: Apollo Scientific

Beschreibung: MAPK/ERK Signalling Pathway

Lieferant: Apollo Scientific

Beschreibung: MAPK/ERK Signalling Pathway

Lieferant: Apollo Scientific

Beschreibung: MAPK/ERK Signalling Pathway

Lieferant: Merck

Beschreibung: Quantum VX Reinstwasser-Patrone, ohne Millipak Endfilter

Artikel-Nr: (APOSBITP1905-1MG)

Lieferant: Apollo Scientific

Hersteller Artikel Nummer : BITP1905-1MG

Beschreibung: Recombinant HIV-2 gp36 (390-702)

UOM: 1 * 1 mg

Sale

Artikel-Nr: (PRSI10-695)

Lieferant: ProSci Inc.

Hersteller Artikel Nummer : 10-695

Beschreibung: Anti-VX-15 Recombinant Antibody

UOM: 1 * 0,1 mg

New Product Sale

Lieferant: Thermo Scientific

Beschreibung: 2-(4-Methoxyphenyl)ethanol ≥98%

Sicherheitsdatenblätter Zertifikate

Lieferant: ANSELL HEALTH CARE

Beschreibung: Schnittfeste Industriehandschuhe für mittlere Beanspruchung.

Artikel-Nr: (BWRLBS5813)

Lieferant: Bioworld Technology

Hersteller Artikel Nummer : BS5813

Beschreibung: Synthetic peptide, corresponding to amino acids 702-747 of Human Na+ CP type IXalpha.

UOM: 1 * 100 µG

Sale

Artikel-Nr: (213-0483)

Lieferant: VWR Collection

Beschreibung: Aus PMP (TPX) hergestellt, kristallklar.

UOM: 1 * 6 ST

Sale

Artikel-Nr: (APOSOR471172-5G)

Lieferant: Apollo Scientific

Hersteller Artikel Nummer : OR471172-5G

Beschreibung: 7-Methyl-1,4-dioxaspiro[4.5]decan-8-one

UOM: 1 * 5 g

Sale

Artikel-Nr: (BOSSBS-13300R-CY3)

Lieferant: Bioss

Hersteller Artikel Nummer : BS-13300R-CY3

Beschreibung: GBE1 is a 702 amino acid protein that is expressed at high levels in muscle and liver and is involved in glycogen biosynthesis. Existing as a monomer, GBE1 catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on a neighboring glycogen chain and, via this catalytic activity, plays an essential role in glycogen accumulation. Defects in the gene encoding GBE1 are the cause of glycogen storage disease type 4 (GSD4) and adult polyglucosan body disease (APBD), the first of which is a metabolic disorder that is associated with the accumulation of polysaccharides and is characterized by liver disease during childhood. Unlike GSD4, APBD is a late-onset disorder that affects the central and peripheral nervous systems and is characterized by cognitive impairment, pyramidal tetraparesis and peripheral neuropathy.

UOM: 1 * 100 µl

Sale

Lieferant: Apollo Scientific

Beschreibung: 3-Amino-1-adamantanol

Lieferant: Thermo Scientific

Beschreibung: 1,3-Dimethyladamantan ≥98%

Sicherheitsdatenblätter Zertifikate

Artikel-Nr: (BOSSBS-13300R-CY5)

Lieferant: Bioss

Hersteller Artikel Nummer : BS-13300R-CY5

Beschreibung: GBE1 is a 702 amino acid protein that is expressed at high levels in muscle and liver and is involved in glycogen biosynthesis. Existing as a monomer, GBE1 catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on a neighboring glycogen chain and, via this catalytic activity, plays an essential role in glycogen accumulation. Defects in the gene encoding GBE1 are the cause of glycogen storage disease type 4 (GSD4) and adult polyglucosan body disease (APBD), the first of which is a metabolic disorder that is associated with the accumulation of polysaccharides and is characterized by liver disease during childhood. Unlike GSD4, APBD is a late-onset disorder that affects the central and peripheral nervous systems and is characterized by cognitive impairment, pyramidal tetraparesis and peripheral neuropathy.

UOM: 1 * 100 µl

Sale

Artikel-Nr: (BOSSBS-13300R-A555)

Lieferant: Bioss

Hersteller Artikel Nummer : BS-13300R-A555

Beschreibung: GBE1 is a 702 amino acid protein that is expressed at high levels in muscle and liver and is involved in glycogen biosynthesis. Existing as a monomer, GBE1 catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on a neighboring glycogen chain and, via this catalytic activity, plays an essential role in glycogen accumulation. Defects in the gene encoding GBE1 are the cause of glycogen storage disease type 4 (GSD4) and adult polyglucosan body disease (APBD), the first of which is a metabolic disorder that is associated with the accumulation of polysaccharides and is characterized by liver disease during childhood. Unlike GSD4, APBD is a late-onset disorder that affects the central and peripheral nervous systems and is characterized by cognitive impairment, pyramidal tetraparesis and peripheral neuropathy.

UOM: 1 * 100 µl

Sale